Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: ALK-Abelló A/S, Bøge Allé 6-8, DK-2970 Hørsholm
Jext 150 micrograms solution for injection in pre-filled pen.
| Pharmaceutical Form |
|---|
|
Solution for injection in pre-filled pen. Clear and colourless solution. |
Jext 150 micrograms: One pre-filled pen delivers one dose of 0.15ml solution for injection containing 150 micrograms of adrenaline (as tartrate).
1 ml solution contains 1mg adrenaline (as tartrate).
Excipients with known effect: Sodium metabisulphite (E223) and sodium chloride.
Jext contains less than 1 mmol sodium (23 mg) per dose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Epinephrine |
Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation. |
| List of Excipients |
|---|
|
Sodium chloride |
Pre-filled pen (single dose pen) comprising an auto-injector with a cartridge. The cartridge is made of glass (type 1), sealed with a latex free grey rubber plunger and a latex free bromobutyl rubber seal within an anodised aluminium cap. The auto-injector is made of plastic.
Exposed needle length:
Jext 150 micrograms: 13 mm.
Jext 300 micrograms: 15 mm.
Pack-size:
Single pack with 1 pre-filled pen. Multipack with 2 pre-filled pens.
Not all pack sizes may be marketed.
ALK-Abelló A/S, Bøge Allé 6-8, DK-2970 Hørsholm
PL10085/0052
Date of first authorisation: 12 October 2010
Date of renewal of the authorisation: 12 October 2015
| Drug | Countries | |
|---|---|---|
| JEXT | Austria, Spain, Finland, France, Hong Kong, Croatia, Ireland, Malta, Netherlands, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
